HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Hawaiian Tropic

This article was originally published in The Rose Sheet

Executive Summary

FDA's final sunscreen monograph December 2002 effective date should be further extended because it does not allow industry enough time to comply, the sunscreen manufacturer says in a July 6 letter to the agency. Because the introduction cycle of a sun care product "is quite long," usually beginning two or three years before the product launch, the financial burden to adjust production "will be incredible," Hawaiian Tropic says. The effective date was postponed a year-and-a-half to provide a "comprehensive monograph" with both UVA and UVB methodologies included (1"The Rose Sheet" Oct. 11, 1999, p. 3)

Latest Headlines
See All
UsernamePublicRestriction

Register

RS008261

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel